The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53

(2015)   Oncotarget

Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1

(2012) F Rizzolio et al.   CELL DEATH AND DIFFERENTIATION

Allosteric Modulators of Steroid Hormone Receptors: Structural Dynamics and Gene Regulation

(2012) Raj Kumar et al.   ENDOCRINE REVIEWS

A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer

(2011) Javier E. Girardini et al.   CANCER CELL

Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines

(2011) Annalisa Roberti et al.   CELL CYCLE

Selective Mutations in Estrogen Receptor α D-domain Alters Nuclear Translocation and Non-estrogen Response Element Gene Regulatory Mechanisms

(2011) Katherine A. Burns et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Critical choices for modeling breast cancer in transgenic mouse models

(2011) Isabella Caligiuri et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Regulation of Estrogen Receptor   N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1

(2011) P. Rajbhandari et al.   MOLECULAR AND CELLULAR BIOLOGY

PI3-Kinase/p38 kinase-dependent E2F1 activation is critical for pin1 induction in tamoxifen-resistant breast cancer cells

(2011) Kwang Youl Lee et al.   MOLECULES AND CELLS

Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases

(2010) Simak Ali et al.   Annual Review of Medicine

Mechanisms of Endocrine Resistance in Breast Cancer

(2010) C. Kent Osborne et al.   Annual Review of Medicine

Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2.

(2010) Christopher C Williams et al.   BMC BIOCHEMISTRY

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

(2010) Georgios P Skliris et al.   ENDOCRINE-RELATED CANCER

The Prolyl Isomerase Pin1 Enhances HER-2 Expression and Cellular Transformation via Its Interaction with Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase 1

(2010) P. Khanal et al.   MOLECULAR CANCER THERAPEUTICS

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

(2009) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation

(2009) Y Liao et al.   ONCOGENE

Low phosphorylation of estrogen receptor   (ER ) serine 118 and high phosphorylation of ER  serine 167 improve survival in ER-positive breast cancer

(2008) H. Yamashita et al.   ENDOCRINE-RELATED CANCER

Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT

(2008) Kristopher J. Stanya et al.   JOURNAL OF CELL BIOLOGY

Epigenetic analysis of the critical region I for premature ovarian failure: demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome

(2008) F Rizzolio et al.   JOURNAL OF MEDICAL GENETICS